{"entity":{"type":"insider","cik":"0001529297","url":"/insider/0001529297","json_url":"/insider/0001529297.json","name":"Howton David T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":16,"first":"2011-09-07","last":"2026-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Howton David T","source":"filing","n_filings":16,"first_seen":"2011-09-07","last_seen":"2026-02-18"}],"transactions":[{"id":5919173,"accession":"0001193125-26-057863","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-057863","line_url":"/filing/0001193125-26-057863#line-2","is_derivative":false,"issuer_cik":"0001529297","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001529297","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7469.0,"shares_display":"7,469","price_per_share":5.8233,"price_display":"5.82","price_state":"stated","total_value":43494.2277,"total_display":"43,494.23","total_whole":"43,494","shares_owned_after":105077.0,"shares_owned_after_display":"105,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-18","scope":"insider"},{"id":5762184,"accession":"0001193125-26-041523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-041523","line_url":"/filing/0001193125-26-041523#line-1","is_derivative":false,"issuer_cik":"0001529297","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001529297","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18894.0,"shares_display":"18,894","price_per_share":6.4419,"price_display":"6.44","price_state":"stated","total_value":121713.2586,"total_display":"121,713.26","total_whole":"121,713","shares_owned_after":97859.0,"shares_owned_after_display":"97,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider"},{"id":5846851,"accession":"0001193125-26-034080","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-034080","line_url":"/filing/0001193125-26-034080#line-3","is_derivative":false,"issuer_cik":"0001529297","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001529297","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37771.0,"shares_display":"37,771","price_per_share":6.4369,"price_display":"6.44","price_state":"stated","total_value":243128.1499,"total_display":"243,128.15","total_whole":"243,128","shares_owned_after":116753.0,"shares_owned_after_display":"116,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-02","scope":"insider"},{"id":4093562,"accession":"0001193125-25-308118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-308118","line_url":"/filing/0001193125-25-308118#line-2","is_derivative":false,"issuer_cik":"0001529297","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001529297","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4932.0,"shares_display":"4,932","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":25202.52,"total_display":"25,202.52","total_whole":"25,203","shares_owned_after":32908.0,"shares_owned_after_display":"32,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4027274,"accession":"0000950170-25-022196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-022196","line_url":"/filing/0000950170-25-022196#line-2","is_derivative":false,"issuer_cik":"0001529297","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001529297","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5561.0,"shares_display":"5,561","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":22021.56,"total_display":"22,021.56","total_whole":"22,022","shares_owned_after":24789.0,"shares_owned_after_display":"24,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-18","scope":"insider"},{"id":3113386,"accession":"0000950170-24-133340","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-133340","line_url":"/filing/0000950170-24-133340#line-2","is_derivative":false,"issuer_cik":"0001529297","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001529297","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5072.0,"shares_display":"5,072","price_per_share":5.5986,"price_display":"5.60","price_state":"stated","total_value":28396.0992,"total_display":"28,396.10","total_whole":"28,396","shares_owned_after":15663.0,"shares_owned_after_display":"15,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-04","scope":"insider"},{"id":8750085,"accession":"0000950170-23-068067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-068067","line_url":"/filing/0000950170-23-068067#line-2","is_derivative":false,"issuer_cik":"0001529297","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001529297","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5367.0,"shares_display":"5,367","price_per_share":2.78,"price_display":"2.78","price_state":"stated","total_value":14920.26,"total_display":"14,920.26","total_whole":"14,920","shares_owned_after":7684.0,"shares_owned_after_display":"7,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-05","scope":"insider"},{"id":3258077,"accession":"0001209191-20-038339","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-038339","line_url":"/filing/0001209191-20-038339","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105122.0,"shares_display":"105,122","price_per_share":170.87604193223112,"price_display":"170.88","price_state":"stated","total_value":17962831.28,"total_display":"17,962,831.28","total_whole":"17,962,831","shares_owned_after":31871.0,"shares_owned_after_display":"31,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-22","scope":"insider","n_lines":4},{"id":8620018,"accession":"0001209191-19-061049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-061049","line_url":"/filing/0001209191-19-061049#line-3","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78000.0,"shares_display":"78,000","price_per_share":125.5,"price_display":"125.50","price_state":"stated","total_value":9789000.0,"total_display":"9,789,000.00","total_whole":"9,789,000","shares_owned_after":25171.0,"shares_owned_after_display":"25,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-17","scope":"insider"},{"id":8168544,"accession":"0001209191-19-058217","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-19-058217","line_url":"/filing/0001209191-19-058217","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":2625000.0,"total_display":"2,625,000.00","total_whole":"2,625,000","shares_owned_after":18703.0,"shares_owned_after_display":"18,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-26","scope":"insider","n_lines":3},{"id":8673928,"accession":"0001209191-19-006630","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-006630","line_url":"/filing/0001209191-19-006630#line-4","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":140.0,"price_display":"140.00","price_state":"stated","total_value":4200000.0,"total_display":"4,200,000.00","total_whole":"4,200,000","shares_owned_after":19571.0,"shares_owned_after_display":"19,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-01","scope":"insider"},{"id":6000489,"accession":"0001209191-18-042890","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-042890","line_url":"/filing/0001209191-18-042890","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":136.46,"price_display":"136.46","price_state":"stated","total_value":6823000.0,"total_display":"6,823,000.00","total_whole":"6,823,000","shares_owned_after":34871.0,"shares_owned_after_display":"34,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-16","filed_date":"2018-07-17","scope":"insider","n_lines":3},{"id":4324319,"accession":"0001209191-17-046036","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-046036","line_url":"/filing/0001209191-17-046036","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":1025000.0,"total_display":"1,025,000.00","total_whole":"1,025,000","shares_owned_after":22301.0,"shares_owned_after_display":"22,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider","n_lines":2},{"id":2478409,"accession":"0001209191-16-142780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-142780","line_url":"/filing/0001209191-16-142780#line-2","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":420000.0,"total_display":"420,000.00","total_whole":"420,000","shares_owned_after":21453.0,"shares_owned_after_display":"21,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-22","filed_date":"2016-09-26","scope":"insider"},{"id":2421475,"accession":"0001209191-16-142355","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-142355","line_url":"/filing/0001209191-16-142355","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9304.0,"shares_display":"9,304","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":465200.0,"total_display":"465,200.00","total_whole":"465,200","shares_owned_after":3168.0,"shares_owned_after_display":"3,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-19","filed_date":"2016-09-21","scope":"insider","n_lines":2},{"id":8929038,"accession":"0001209191-11-046867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-046867","line_url":"/filing/0001209191-11-046867#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001529297","owner_name":"Howton David T","owner_display_name":"Howton David T","owner_url":"/insider/0001529297","role":"Officer (SVP)","role_mark":"O","role_mark_label":"Officer (SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":328.0,"shares_display":"328","price_per_share":44.29,"price_display":"44.29","price_state":"stated","total_value":14527.12,"total_display":"14,527.12","total_whole":"14,527","shares_owned_after":9271.0,"shares_owned_after_display":"9,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001707502","name":"Solid Biosciences Inc.","url":"/issuer/0001707502","role":"Officer (Chief Operating Officer)","n_filings":7,"first_seen":"2023-12-05","last_seen":"2026-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Officer (EVP, General Counsel)","n_filings":8,"first_seen":"2016-09-21","last_seen":"2020-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (SVP)","n_filings":1,"first_seen":"2011-09-07","last_seen":"2011-09-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001529297","retrieved_at":"2026-08-24T08:45:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}